NASDAQ:HUMA News 12 November 2025

Humacyte (HUMA) Q3 2025: Symvess Sales Surge; IND Filed for CABG as Dialysis Data Advance — Nov 12, 2025

Durham, N.C. — November 12, 2025 — Humacyte, Inc. (NASDAQ: HUMA) reported third‑quarter results and a pipeline update this morning, highlighting accelerating Symvess™ sales, new clinical data in dialysis access, and a key regulatory step toward first‑in‑human testing of its coronary bypass graft. GlobeNewswire What Humacyte reported Humacyte posted $753,000 in Q3 revenue—$703,000 from Symvess, the FDA‑approved acellular tissue‑engineered vessel (ATEV) for adult extremity vascular trauma, and ~$100,000 from a collaboration with a large med‑tech partner. Management emphasized a step‑up in VAC approvals and hospital onboarding as the key driver of the sales ramp. GlobeNewswire On profitability, the company recorded

12 November 2025

Biotechnology·Clinical Trials·Earnings Reports·NASDAQ:HUMA

CSL share price in focus after ASX sell-off: what investors watch before Feb 11 results

7 February 2026

Sydney, February 7, 2026, 16:48 AEDT — Market closed. CSL Limited shares ended Friday down 0.4% at A$180.50, a small move for the ASX healthcare heavyweight as traders look ahead to the company’s half-year numbers next week. The stock ranged between A$179.29 and A$183.31. (Reuters) The broader S&P/ASX 200 closed down 2.03% at 8,708.80, underscoring how quickly risk appetite has thinned out into the weekend. (Yahoo Finance) That matters for CSL now because it is one of the market’s biggest index drivers, and its earnings update lands as investors are jumpy and short on patience. A steady result can still

WiseTech Global share price slides to A$47.60 as AI fears batter ASX tech — what to watch next

7 February 2026

WiseTech Global shares fell 4.6% to A$47.60 Friday, with turnover at 3.61 million shares, amid a broader selloff in software stocks. The S&P/ASX 200 dropped 2.03%, its worst session since November, and WiseTech is down 28.7% for the month. U.S. software stocks have lost about $1 trillion since Jan. 28. WiseTech’s half-year results are due Feb. 25.

Macquarie Group share price slips 2% after APRA eases liquidity curbs — what to watch next week

7 February 2026

Macquarie Group shares fell 2.17% to A$207.83 Friday, marking a third straight decline as the ASX 200 slid 2%. Australia’s regulator trimmed liquidity requirements for Macquarie Bank after improvements in controls. Macquarie Asset Management announced two UK utility deals, including full ownership of Last Mile Infrastructure and the purchase of Energy Assets Group. Investors await Tuesday’s operational briefing.

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 07.02.2026

7 February 2026

LIVEMarkets rolling coverageStarted: February 7, 2026, 12:00 AM ESTUpdated: February 7, 2026, 1:13 AM EST Crude Oil Prices Rise on Dollar Weakness, Geopolitical Tensions February 7, 2026, 12:52 AM EST. Crude oil prices edged higher on Friday, supported by a weaker U.S. dollar and escalating geopolitical risks in the Middle East. March WTI crude gained 0.41%, rebounding from early losses, while gasoline prices rose 1.38%. Doubts over a U.S.-Iran nuclear deal loom after reports of Iran's refusal to halt uranium enrichment, raising the risk of military action and potential disruption of vital shipping routes. Additionally, a surge in U.S. consumer